Influence of Pathogenic and Metabolic Genes on the Pharmacogenetics of Mood Disorders in Alzheimer's Disease

• Hlavní autoři: Ramón Cacabelos (Autor), Juan C. Carril (Autor), Lola Corzo (Autor), Lucía Fernández-Novoa (Autor), Rocío Pego (Autor), Natalia Cacabelos (Autor), Pablo Cacabelos (Autor), Margarita Alcaraz (Autor), Iván Tellado (Autor), Vinogran Naidoo (Autor)
• Médium: Kniha
• Vydáno: MDPI AG, 2021-04-01T00:00:00Z.
• Témata: article
• On-line přístup: Connect to this object online.

Background: Mood disorders represent a risk factor for dementia and are present in over 60% of cases with Alzheimer's disease (AD). More than 80% variability in drug pharmacokinetics and pharmacodynamics is associated with pharmacogenetics. Methods: Anxiety and depression symptoms were assessed...